Medicine
Is produce from a home garden safer than store bought? 'It depends'
Home gardening is getting a boost, in part, from fears of foodborne illness. But is homegrown safer? Experts weigh in.
STAT+: HHS unveils new initiatives to reduce animal testing in drug development
For the second time this year, HHS announced new strategies to speed the away from animals in medical testing.
Opinion: Former FDA commissioners: Heidi Overton has an opportunity to strengthen the FDA
Two former FDA commissioners: Heidi Overton is the right pick in a difficult moment.
Sex-based discrimination in medicine costs lives | Letters
Readers respond to an article on women being less likely than men to be offered active treatment for the same conditionsAs head of pharmacovigilance at a clinical trials technolog…
Minority ethnic NHS staff pay a heavy price for speaking up about patient safety | Letter
Providing psychological safety to Black, Asian and ethnic minority staff so they can raise concerns about patient care without fear would save lives, write Dr Jennifer Creese, Dr …
STAT+: Did the Trump administration just cut Novo a huge financial win?
The White House's GENEROUS plan was designed to make drugs more affordable for Medicaid users. There's one glaring potential exception.
Big tech says AI can find a cure for cancer. So where is it?
Alongside warnings about its ability to destroy humanity, artificial intelligence is also hailed for its potential to revolutionise health treatment. Just how far can it take us?H…
STAT+: Novo may be getting a better deal than expected with Medicare’s Bridge program
Eli Lilly and Novo Nordisk were already benefitting a great deal from the Trump administration's pilot program covering obesity drugs for seniors at a price of $245 a month. It…
STAT+: Epic’s mortality model, and Omada’s future products
In this edition of STAT Health Tech: What Epic's mortality prediction algorithm tells us about AI in geriatrics, Omada's expansion plans, and more.
STAT+: Pharmalittle: We’re reading about pharma seeking to protect China deals, a Roche obesity drug, and more
Western pharmaceutical companies are urging the Trump administration to allow them to keep doing deals with Chinese companies for drug candidates
New federal autism committee head has financial ties to leucovorin
RFK Jr. has installed John Gaitanis, a pediatric neurologist, as the new chair of the Interagency Autism Coordinating Committee, which helps the federal government decide how to a…
Prison Letters: the teenager writing letters to jailed climate activists – documentary
A teenager struggling with climate anxiety searches for hope in an unexpected place – writing letters to imprisoned activists. Max, 14, is on a quest to understand the human stori…
Why the CDC is excluding measles deaths in Pennsylvania even as outbreak appears to be ‘accelerating’
Centers for Disease Control and Prevention refuses to count four measles deaths in the state though doctors are ‘seeing new forms’ of diseaseThe US Centers of Disease Control and …
Abortion is on the ballot again as post-Roe policies continue to evolve
Four states will vote on abortion-related ballot measures in November. The measures follow the Supreme Court's "Dobbs" decision, which upended federal abortion protections.
Your smartwatch isn't accurately counting how many calories you burn, study says
A new study finds that consumer-grade fitness wearables are generally inaccurate when calculating calories burned. NPR's Leila Fadel speaks with the study's lead author Jason Kost…
Opinion: The science on relieving cancer symptoms is clear. Why isn’t insurance paying?
Research shows that integrative therapies reduce cancer-related pain, fatigue, anxiety, and nausea. Why won't insurance pay?
Opinion: Social media bans are passing around the world. How will we know if they help teens?
“Researchers must seize this opportunity to examine how social media — and its regulation — impacts teenagers,” writes Wellcome’s Camilla Iannone.
STAT+: Why an influential GOP health policy expert still backs the Medicaid cuts — and which policy target is next
Why an influential GOP health policy expert still backs $1 trillion in Medicaid cuts — and which policy target is next.
STAT+: Ohio governor’s race is a battle over Covid, health costs, and trust in science
The race between Amy Acton and Vivek Ramaswamy could be the election’s most direct test of where the heartland stands on health care and the pandemic.
The rise of Big Toothbrush: how did our mouths become such a lucrative market?
People in the UK are more interested in oral health than ever - and you can now buy prebiotic toothpastes and brushes that cost up to £600. Yet we remain in the midst of a serious…
Young people’s Pip claims for ADHD and autism ‘rising fastest in affluent areas’
Experts say trend across England probably reflects swifter access to diagnoses as wealthier families go privateSome of the most affluent areas of England have had the sharpest ris…
Martha’s rule to be expanded to every A&E in England
System gives patients, loved ones and health workers the right to ask for a second opinion on careMartha’s rule, which lets NHS patients, staff and relatives request a review of t…
Cut NHS red tape and boost productivity to prevent 20,000 early deaths a year in England, report urges
Changes could save £33bn and result in average of four extra years of good health for people, report saysThe NHS in England could prevent 20,000 deaths and save £33bn a year by cu…
STAT+: Members of Congress push back on plan to create a commission of political appointees to review NIH grants
Several members of Congress voiced strong opposition about a reported plan to create a panel of political appointees to sign off on NIH grants